Esophagogastric Cancer clinical trials

Explore recruiting esophagogastric cancer clinical trials.

Recruiting esophagogastric cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Esophagogastric Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and Preliminary Clinical Efficacy of MT-302 with CapOx based regimens in metastatic esophagogastric cancer (SPaCE-MT)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Anti-PD-1, Capecitabine, and Oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Blood-borne assessment of stromal activation in esophageal adenocarcinoma to guide tocilizumab therapy: a randomized phase II proof-of-concept study (BASALT)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase I, open-label, multi-center study of KFA115 as a single agent and in combination with pembrolizumab in patients with select advanced cancers

Italy, Spain, France, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Esophagogastric Cancer trials by city

Esophagogastric Cancer clinical trials

Recruiting esophagogastric cancer studies right now

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Folfox+Irinotecan+Chemort In Esophageal Cancer

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique

Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma

Perioperative FLOT vs Adjuvant XELOX for CA Stomach

QL1706 Combined With SOX Used in Theperioperative Treatment

Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial

Also recruiting in Europe

Safety and Preliminary Clinical Efficacy of MT-302 with CapOx based regimens in metastatic esophagogastric cancer (SPaCE-MT)

Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX)

Anti-PD-1, Capecitabine, and Oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle study

Blood-borne assessment of stromal activation in esophageal adenocarcinoma to guide tocilizumab therapy: a randomized phase II proof-of-concept study (BASALT)

A phase I, open-label, multi-center study of KFA115 as a single agent and in combination with pembrolizumab in patients with select advanced cancers

Esophagogastric Cancer trials by city

Other conditions